0000000000448255

AUTHOR

Francesco De Cobelli

showing 3 related works from this author

Validation of the easy-to-use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinib

2022

Aim The identification of new prognostic factors able to stratify hepatocellular carcinoma patients candidate to first-line therapy is urgent. In the present work we validated the prognostic value of the lenvatinib prognostic index. Methods Data of Eastern and Western patients treated with lenvatinib as first-line for Barcelona Clinic Liver Cancer stage B or C hepatocellular carcinoma were recollected. The lenvatinib prognostic index was composed by three classes of risk according with our previous study. The "low risk" group includes patients with prognostic nutritional index (PNI) >43.3 and with previous transarterial chemoembolization. The "medium risk" group includes patients with PN…

Infectious DiseasesHepatologyprognostic factorshepatocellular carcinomalenvatinib
researchProduct

Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy

2021

Valentina Burgio,1 Massimo Iavarone,2 Giovanni Giuseppe Di Costanzo,3 Fabio Marra,4 Sara Lonardi,5,6 Emiliano Tamburini,7 Fabio Piscaglia,8 Gianluca Masi,9,10 Ciro Celsa,11 Francesco Giuseppe Foschi,12 Marianna Silletta,13 Daniela Caterina Amoruso,14 Margherita Rimini,15 Mariangela Bruccoleri,2 Raffaella Tortora,3 Claudia Campani,4 Caterina Soldà,6 Massimo Giuseppe Viola,16 Antonella Forgione,8 Fabio Conti,12 Francesca Salani,9,10 Silvia Catanese,9,10 Carmelo Marco Giacchetto,17 Claudia Fulgenzi,13 Carmine Coppola,14 Pietro Lampertico,18 Antonio Pellino,6,19 Gabriele Rancatore,17 Giuseppe Cabibbo,17 Francesca Ratti,20 Federica Pedica,21 Angelo Della Corte,22 Massimo Colombo,18 Francesco De…

Oncologysorafenib.Cancer Management and ResearchhepatocarcinomaNeoplasms. Tumors. Oncology. Including cancer and carcinogenssorafeniblenvatinibneoplasmsdigestive system diseasesRC254-282Original ResearchCancer Management and Research
researchProduct

Lights and shadows of cardiac magnetic resonance imaging in acute myocarditis

2016

Cardiac magnetic resonance (CMR) is considered a primary tool for the diagnosis of acute myocarditis, due to its unique potential for non-invasive identification of the various hallmarks of the inflammatory response, with relevant impact on patient management and prognosis. Nonetheless, a marked variation in sensitivity and negative predictive value has been reported in the literature, reflecting the intrinsic drawbacks of current diagnostic criteria, which are based mainly on the use of conventional CMR pulse sequences. As a consequence, a negative exam cannot reliably exclude the diagnosis, especially in patients who do not present an infarct-like onset of disease. The introduction of new…

Opinionmedicine.medical_specialtyacute myocarditis; cardiac magnetic resonance; Lake Louise criteria; T1 mappingDisease030204 cardiovascular system & hematologycardiac magnetic resonance030218 nuclear medicine & medical imaging03 medical and health sciencesacute myocarditis0302 clinical medicineCardiac magnetic resonance imagingNuclear Medicine and ImagingAcute myocarditimedicineRadiology Nuclear Medicine and imagingIn patientSettore MED/36 - DIAGNOSTICA PER IMMAGINI E RADIOTERAPIANeuroradiologymedicine.diagnostic_testbusiness.industryInterventional radiologyT1 mappingAcute myocarditis; Cardiac magnetic resonance; Lake Louise criteria; T1 mapping; Radiology Nuclear Medicine and ImagingAcute myocarditisLake Louise criteriacardiovascular systemDiffuse diseaseRadiologyRadiologyCardiac magnetic resonancebusinessInsights into Imaging
researchProduct